UNSPSC 51411608: Tenitramine

This classification denotes an ethylenediamine with the molecular formula C10H20N6O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CKB16BAQ3S, chemically known as n,n,n,n-tetrakis(2-hydroxyethyl)ethylenediaminetetranitrate but generally known as tenitramine, which bears US NIH Compound Identifier 168009. European Medicines Agency schedules Tenitramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15485MIG.

World Health Organization schedules tenitramine in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, TENITRAMINE remains the US FDA Preferred Term for this commodity. SMILES: C(CN(CCO[N+](=O)[O-])CCO[N+](=O)[O-])N(CCO[N+](=O)[O-])CCO[N+](=O)[O-].

UNSPSC 51411608 Tenitramine (Commodity) encompasses emergency medical medications supplied to fire rescue and emergency services operations. In practice, state and local governments procure specific injectable advanced life support drugs — including epinephrine, adenosine, labetalol, and diltiazem formulations — for use by paramedics and emergency medical technicians in acute care settings. Issuing bodies include municipal fire departments and city purchasing offices acting on behalf of emergency medical services divisions. Suppliers must meet strict expiration and shelf-life requirements, typically nine months or more remaining from acceptance, and warrant product integrity for a full year. Delivery expectations are short — often ten calendar days or less — reflecting the critical-use profile and rotation protocols in emergency response. Procurement vehicles commonly include sealed bid solicitations with firm pricing that encompasses freight, handling, and applicable taxes.

The City of Tampa's Purchasing Department issued IFB 26P00188 in April 2026 for Advanced Life Support Medications to supply Tampa Fire Rescue in Hillsborough County, Florida, with a sealed-bid deadline of April 8, 2026 and an estimated contract value of $40,000.00. The solicitation specified four medication line items totaling approximately 3,530 units (370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials), with one-year contract term and two optional renewal periods. Award criteria centered on lowest responsive, responsible bidder, with a 5 percent bid discount available to Small Local Business Enterprise (SLBE) participants capped at $10,000. The opportunity required vendors to provide OSHA-compliant Safety Data Sheets, WCAG 2.2 Level AA accessibility documentation, and subcontractor disclosure forms when SLBEs participated. Recent activity under this code concentrates in Florida; no additional state or local solicitations appear in the current opportunity set.